Non-alcoholic fatty liver disease (NAFLD), typified by the accumulation of lipids in hepatocytes, is strongly associated with obesity and the metabolic syndrome with a hallmark of insulin resistance (IR) (1) . Simple steatosis can progress to non-alcoholic steatohepatitis (NASH) which may lead to cirrhosis and hepatocellular carcinoma 1 . It has been documented that inflammation, pro-inflammatory cytokines and oxidative stress play key roles in the pathogenesis of NAFLD (1, 2) . Evidence from previous studies has shown an inverse relationship between serum 25(OH) D levels and IR, diabetes risk and metabolic syndrome (3) , suggesting a possible role for vitamin D in the pathogenesis of NAFLD. Previous studies have demonstrated that fatty acids: oleic acid (OA) and palmitic acid (PA) induce significant lipid accumulation in hepatocytes while PA induces significant neutrophil chemoattractant, IL-8 in hepatocytes (2) . The specific aim of this study was to investigate the effect of vitamin D supplementation / pre-treatment on the release of pro-inflammatory cytokines (IL-8).
